CNE000000NN2
CNE000000NN2
GENIMOUS TECHNOLOGY
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 8.5B EUR | 6.44B EUR | 9.57B EUR |
Enterprise Value | 7.34B EUR | 6B EUR | 9.12B EUR |
Valuation Multiples | |||
Trailing P/E | 39.71x | 31.61x | 63.45x |
Forward P/E | 16.88x | -- | -- |
Price to Sales | 2.09x | 1.52x | 2.27x |
Price to Book | 1.96x | 1.49x | 2.24x |
EV/Revenue | 1.81x | 1.42x | 2.16x |
EV/EBITDA | 65.43x | 18.15x | 31.25x |
Price to FCF (P/FCF) | 91.06x | 49.13x | -- |
EV/FCF | 78.63x | 45.8x | -- |
FCF Yield | 1.1% | 2.04% | -1.76% |